无水乙醇注射联合肝动脉栓塞化疗治疗原发性肝癌患者效果分析*

doi:10.3969/j.issn.1672-5069.2016.01.029

Abstract

Li Dexiu, Zou Can. Effects of percutaneous ethanol injection and transcatheter arterial chemoembolization in treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 100-101.

References

[1] 汤衍斌,林增海,马涛. 大肝癌治疗的临床研究现状. 临床合理用药杂志,2012,5（11）：171-172.
[2] 帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价.介入放射学杂志,2012,21（12）：322-326.
[3] Federico A,Orditura M,Cotticelli G,et al. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis. Oncol Lett, 2015,9（4）:1628-1632.
[4] 苏飞,王欣,陈双倩,等. 经肝动脉化疗栓塞术联合无水乙醇瘤内注射治疗原发性肝癌的Meta分析.中华实验外科杂志,2014,31（7）：1553-1555.
[5] 纪民,蒲春文,李本科,等. 肝动脉化疗栓塞同步经皮肝穿瘤内无水乙醇注射治疗原发性肝癌.中国肝脏病杂志（电子版）,2014,3（11）：28-30.
[6] 邓俊,陈卫,陆忠华,等. 原发性肝癌患者射频消融治疗前后外周血T细胞亚群及NK细胞的变化. 使用肝脏病杂志,2013,16（5）：416-418.
[7] 方志雄,程丹,方志宏,等.肝动脉化疗栓塞联合射频消融治疗大肝癌疗效评价.中华临床医师杂志：电子版,2012,6（6）：2823-2825.
[8] 赵明,王健鹏,吴沛宏,等.经导管肝动脉化疗栓塞与经导管肝动脉化疗栓塞联合RFA治疗中晚期原发性肝癌167例临床对比分析.中华医学杂志,2010,90（3）：2916-2921.
[9] Yang B,Zan RY,Wang SY,et al. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma:a meta-analysis of randomized controlled trials. World J Surg Oncol, 2015,13（1）:96.
[10] 刘德鑫,李华东,李新丰,等. 肝动脉栓塞化疗联合射频及无水乙醇注射治疗中晚期肝癌的评价.介入放射学杂志,2009,18（9）：389-391.
[11] 肖景坤,吕维富,周春泽,等. 原发性肝癌伴动静脉瘘介入栓塞治疗62例回顾性分析. 介入放射学杂志,2014,23（8）：683-687.
[12] 张福君,吴沛宏,赵明,等. 肝动脉栓塞化疗后射频消融联合酒精消融对原发性肝癌的疗效评价.中华肿瘤杂志,2005,27（8）：248-250.
[13] Kang SD,Kim JW,Jwa YJ,et al. Treatment of hepatocellular carcinoma in elderly patients.Hepatogastroenterology,2014,61（135）:2001-2008.
[14] 郑加生,孙斌,生守鹏,等.合并门静脉癌栓的原发性肝癌的综合介入治疗. 中国介入影像与治疗学,2011,8（11）：86-89.
[15] 梁先兰,齐丽英,米泉清,等.不同类型肝癌的常规超声检查及无水乙醇超声介入治疗效果观察.中国综合临床,2015,31（1）：39-42.
[16] Huang H,Liang P,Yu XL,et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.Int J Hyperthermia,2015,31（1）:40-47.
[17] 薛元领.不同栓塞模式在介入治疗原发性肝癌中的应用. 微创医学,2014,9（2）：229-231.

Effects of percutaneous ethanol injection and transcatheter arterial chemoembolization in treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[2]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[3]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Huang Shiying, Liang Shuang, Wei Yanghui, et al. Efficacy of CAO chemotherapy regimen combined with high frequency focused ultrasound ablation in the treatment of children with hepatoblastoma at stage III/IV [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 569-572.
[6]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[7]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[8]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[9]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[10]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.
[13]	Zheng Xu，Qiu Xiong，Shao Zeyong，Luo Wenjie, Tang Shixiao. Changes of serum CEMIP, CA19-9 and CA242 levels in patients with pancreatic cancer and their clinical significance [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 280-284.
[14]	Zhao Xitai, Nie Qinghe. Serum microRNA in diagnosis of patients with hepatocellular carcinoma and methodological progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 297-300.
[15]	Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.